- Alongside its traditional set of offerings for the Chinese-speaking investment community, ChineseInvestors.com is making strategic moves to capitalize on the burgeoning CBD oil industry
- Alex Hamilton has been appointed as chief financial officer of subsidiary company CBD Biotechnology, LTD
- ChineseInvestors.com recognizes the unprecedented industry potential of CBD-based nutrition and wellness products and hopes to offer them to mainland China
ChineseInvestors.com, Inc. (OTCQB: CIIX), a premier provider of financial information to Chinese-speaking investors in the United States and China, recently announced the appointment of Alex Hamilton as chief financial officer of CBD Biotechnology, LTD, the company’s wholly owned subsidiary. Hamilton will be supervising a myriad of corporate responsibilities within the company and, ultimately, aims to execute CBD Biotech’s goal of providing cannabidiol (CBD)-related products to China’s mainland population, which Hamilton (http://cnw.fm/1MAmJ) calls the “largest market ever.”
“I am humbled by this appointment and look forward to unlocking a lot of value with the spin-off,” Hamilton stated in a news release (http://cnw.fm/8Tocy). “This is an exciting opportunity for rapid growth.”
Recognizing increased demand for cannabidiol-based health and wellness products, ChineseInvestors.com is building a foundation to capitalize on the unprecedented opportunity. While the CBD-based product market has been steadily growing around the world and is predicted to become a $2.1 billion dollar industry by 2020, the nutrition and health products market of mainland China has yet to fully take advantage of the health benefits of CBD oil. ChineseInvestors.com seeks to capitalize on this market opportunity, which encompasses an enormous population of consumers.
Under a wholesale agreement with a reputable CBD health brand, the company has already launched the world’s first online CBD health products store published in the Chinese language, www.ChineseCBDOil.com. Additionally, it has launched a cannabis-focused mobile app, Da Ma Dian Ping, the first marijuana social media mobile app created for Chinese-speaking customers around the world.
As it positions itself to become a global player in the CBD-based product industry, ChineseInvestors.com continues to focus on its original mission of providing financial information and services to the larger Chinese community in the U.S. and abroad. The company’s extensive list of products and services includes real-time market commentary; analysis and education-related services in Chinese language character sets; consultative services to smaller private companies desiring to become public; and public relations-related support services, including advertising.
For more information, visit the company’s website at www.ChineseInvestors.com
More from CannabisNewsWire
About CBDWire
CBDWire (CBDW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CBDNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CBDW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled visibility, recognition and brand awareness. CBDW is where news, content and information converge.
CBDWire is at the epicenter of the Cannabis Revolution.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cbdwire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
CBDWire (CBDW)
Denver, Colorado
cbdwire.com
303.498.7722 Office
Editor@CBDWire.com
